Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1 Immune Checkpoint Inhibitor (ICI) in Metastatic Clear Cell (mcc) Renal Cell Carcinoma (RCC): Result...

Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1 Immune Checkpoint Inhibitor (ICI) in Metastatic Clear Cell (mcc) Renal Cell Carcinoma (RCC): Result...

kidneycancer

4 weeks
32 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Chung-Han Lee1, Amishi Y. Shah2, Vicky Makker1, Matthew Taylor3, David Shaffer4, James J. Hsieh5, Allen L. Cohn6, Chris DiSimone7, Alvaro Pinto Marin8, Drew Rasco9, Sara Gunnestad Ribe10, Donald A. Richards11, Daniel E. Stepan*, Corina E. Dutcus12, Jane Wu12, Emmett V. Schmidt13, Rodolfo Perini13, Robert Motzer1 1Memorial Sloan Kettering Cancer Center, New York, NY, USA; 2MD Anderson Cancer Center, University of Texas, Houston, TX, USA; 3Oregon Health and Science University; Portland, OR, USA; 4New York Oncology Hematology, Albany, NY, USA; 5Washington University School of Medicine, St. Louis, MO, USA; 6Rocky Mountain Cancer Center, Denver, CO, USA; 7Arizona Oncology Associates, Tucson, AZ, USA; 8Hospital Universitario La Paz, Madrid, Spain; 9South Texas Accelerated Research Therapeutics, San Antonio, TX, USA; 10Sorlandet Hospital, Kristiansand, Norway; 11Texas Oncology, US Oncology Research, Tyler, TX, USA; 12Eisai Inc., Woodcliff Lake, NJ, USA; 13Merck & Co. Inc., Kenilworth, NJ, USA. *Formerly of Eisai Inc. 18th International Kidney Cancer Symposium 2019, Miami, FL.

__________

Interview here: https://www.oncologytube.com/video/phase-2-study-of-lenvatinib-plus-pembrolizumab-for-disease-progression-after-pd-1-pd-l1

Up Next Autoplay
Treatment-Free Survival, With and Without Toxicity
Treatment-Free Survival, With and Without Toxicity
Category: Kidney Cancer
12 Views
kidneycancer 1 week
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
Category: Kidney Cancer
2 Views
kidneycancer 1 week
What's To Come in Modern Imaging Technology
What's To Come in Modern Imaging Technology
Category: Kidney Cancer
4 Views
kidneycancer 1 week
Modern Imaging Technology
Modern Imaging Technology
Category: Kidney Cancer
11 Views
kidneycancer 1 week
Management of Clinical Cases in Kidney Cancer
Management of Clinical Cases in Kidney Cancer
Category: Kidney Cancer
17 Views
kidneycancer 1 week
Kidney Cancer Program & SPORE
Kidney Cancer Program & SPORE
Category: Kidney Cancer
10 Views
kidneycancer 1 week
Front Line TKI Based Treatment For Non-Clear Cell RCC
Front Line TKI Based Treatment For Non-Clear Cell RCC
Category: Kidney Cancer
35 Views
kidneycancer 2 weeks
Consolidative Surgery in the IO Era @WinshipAtEmory
Consolidative Surgery in the IO Era @WinshipAtEmory
Category: Kidney Cancer
17 Views
kidneycancer 2 weeks
Management of Small Renal Masses @RutgersCancer @eric_facs
Management of Small Renal Masses @RutgersCancer @eric_facs
Category: Kidney Cancer
21 Views
kidneycancer 2 weeks
Cystic Renal Mass Treatment
Cystic Renal Mass Treatment
Category: Kidney Cancer
17 Views
kidneycancer 3 weeks